Cargando…
Nanomedicine-mediated alteration of the pharmacokinetic profile of small molecule cancer immunotherapeutics
The advent of immunotherapy is a game changer in cancer therapy with monoclonal antibody- and T cell-based therapeutics being the current flagships. Small molecule immunotherapeutics might offer advantages over the biological drugs in terms of complexity, tissue penetration, manufacturing cost, stab...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471422/ https://www.ncbi.nlm.nih.gov/pubmed/32451411 http://dx.doi.org/10.1038/s41401-020-0425-3 |